Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Emd128130
2. Sarizotan Hydrochloride
1. Sarizotan [inn]
2. 351862-32-3
3. 467lu0ucuw
4. Emd-77697
5. 1-[(2r)-3,4-dihydro-2h-chromen-2-yl]-n-[[5-(4-fluorophenyl)pyridin-3-yl]methyl]methanamine
6. 1-(5-(4-fluorophenyl)pyridin-3-yl)-n-((2r)-3,4,4a,8a-tetrahydro-2h-chromen-2-ylmethyl)methanamine
7. 3-pyridinemethanamine, 5-(4-fluorophenyl)-n-(((2r)-3,4,4a,8a-tetrahydro-2h-1-benzopyran-2-yl)methyl)-
8. Unii-467lu0ucuw
9. (-)-(r)-n-(3,4-dihydro-2h-1-benzofuran-2-ylmethyl)-n-[5-(4-fluorophenyl)-3-pyridylmethyl]amine
10. 195068-07-6
11. Sarizotan [mi]
12. Sarizotan [who-dd]
13. Schembl120080
14. Chembl220808
15. Zinc21067
16. Bdbm50027256
17. Db06454
18. Hy-100820
19. Cs-0020461
20. A1-26903
21. Q7424144
22. (r)-(+)-2-[5-(4-fluorphenyl)-3-pyridylmethylaminomethyl]-chromane
23. (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chroman
24. (r)-1-(chroman-2-yl)-n-((5-(4-fluorophenyl)pyridin-3-yl)methyl)methanamine
25. 3-pyridinemethanamine, N-(((2r)-3,4-dihydro-2h-1-benzopyran-2-yl)methyl)-5-(4-fluorophenyl)-
| Molecular Weight | 348.4 g/mol |
|---|---|
| Molecular Formula | C22H21FN2O |
| XLogP3 | 4.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 5 |
| Exact Mass | 348.16379146 g/mol |
| Monoisotopic Mass | 348.16379146 g/mol |
| Topological Polar Surface Area | 34.2 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 426 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in schizophrenia and schizoaffective disorders and parkinson's disease.
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
55
PharmaCompass offers a list of Sarizotan API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sarizotan manufacturer or Sarizotan supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sarizotan manufacturer or Sarizotan supplier.
PharmaCompass also assists you with knowing the Sarizotan API Price utilized in the formulation of products. Sarizotan API Price is not always fixed or binding as the Sarizotan Price is obtained through a variety of data sources. The Sarizotan Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sarizotan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sarizotan, including repackagers and relabelers. The FDA regulates Sarizotan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sarizotan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sarizotan supplier is an individual or a company that provides Sarizotan active pharmaceutical ingredient (API) or Sarizotan finished formulations upon request. The Sarizotan suppliers may include Sarizotan API manufacturers, exporters, distributors and traders.
Sarizotan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sarizotan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sarizotan GMP manufacturer or Sarizotan GMP API supplier for your needs.
A Sarizotan CoA (Certificate of Analysis) is a formal document that attests to Sarizotan's compliance with Sarizotan specifications and serves as a tool for batch-level quality control.
Sarizotan CoA mostly includes findings from lab analyses of a specific batch. For each Sarizotan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sarizotan may be tested according to a variety of international standards, such as European Pharmacopoeia (Sarizotan EP), Sarizotan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sarizotan USP).
